Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H SFOSF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $2.20
- Day Range
- $1.95–1.95
- 52-Week Range
- $1.95–3.50
- Bid/Ask
- $1.37 / $3.62
- Shares Outstanding
- 2.67B
- Market Cap
- $5.21B
- Volume/Avg
- 100 / 8,840
Key Statistics
- Price/Earnings (Normalized)
- 13.88
- Price/Sales
- 0.98
- Dividend Yield (Trailing)
- 2.61%
- Dividend Yield (Forward)
- 2.61%
- Total Yield
- 2.61%
Company Profile
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers mergers and acquisitions as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 40,603
- Website
- https://www.fosunpharma.com
Valuation
|
Metric
|
SFOSF
|
|---|---|
Price/Earnings (Normalized) | 13.88 |
Price/Book Value | 0.83 |
Price/Sales | 0.98 |
Price/Cash Flow | 7.82 |
Price/Earnings
SFOSF
Financial Strength
|
Metric
|
SFOSF
|
|---|---|
Quick Ratio | 0.71 |
Current Ratio | 0.93 |
Interest Coverage | 4.92 |
Quick Ratio
SFOSF
Profitability
|
Metric
|
SFOSF
|
|---|---|
Return on Assets (Normalized) | 2.03% |
Return on Equity (Normalized) | 5.04% |
Return on Invested Capital (Normalized) | 3.26% |
Return on Assets
SFOSF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|G#$?!FS | LOCK|G#<y | $72B | |||
| Haleon PLC ADR
HLN
| LOCK|fFN>&RH | LOCK|dcK | $44B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|yc@Xlt& | LOCK|XL?g | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|^rPG#bP | LOCK|xk& | $30B | |||
| Viatris Inc
VTRS
| LOCK|LsbxcX@ | LOCK|nzC | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|^&k | LOCK|Q^n | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|$V^#%$> | LOCK|#!& | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|w$$N&$ | LOCK|H<W | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|^#rbrLB | LOCK|q!Q<R | $3B | |||
| Perrigo Co PLC
PRGO
| LOCK|x?%@!f | LOCK|<l | $2B |
United States